Study of Sexual Health in Peri and Postmenopausal Solid Organ Transplant Recipients

74% of female transplant recipients reported no provider had asked about sexual health in the past year

Journal: Clinical Transplantation | Published: 2026-03 | Type: Cross-sectional study | PMID: 41879649 Authors: Polavarapu M, Nair S, Jadlowiec C, Werner KT, Mi L, Quillen J, Ali M, Vegunta S (Mayo Clinic Arizona, Scottsdale) Funding/COI: Not listed for either

Summary

Among 277 female solid organ transplant (SOT) recipients surveyed at a single Mayo Clinic center, peri/postmenopausal women were significantly less likely to be sexually active and reported lower desire, arousal, and lubrication scores compared to premenopausal recipients. The most striking finding isn't the dysfunction rates — it's the care gap: roughly three-quarters of the entire cohort hadn't been asked about sexual health by any provider in the prior year. The study doesn't tell us why or what to do about it, but it documents the gap clearly.

Claims

• 48.9% of peri/postmenopausal SOT recipients were sexually active vs. 69.4% of premenopausal recipients (p = 0.002)
• Peri/postmenopausal recipients reported lower FSFI scores for desire, arousal, and lubrication domains; higher FSDS scores (greater sexual distress)
• Sexual distress negatively correlated with quality of life across both menopausal groups
• Overall QoL was rated highly in both groups despite sexual dysfunction — suggesting women adapt or deprioritize this concern
• ~74% of the full cohort had not been asked about sexual health by any provider in the past year
• Sexual dysfunction rates in this population appear higher than the general population estimate of 10–15% for sexual distress in midlife women

Study Quality

This is a cross-sectional survey — it captures a snapshot, not a trajectory. Validated instruments were used (FSFI for function, FSDS for distress, MRS for menopausal symptoms, LASA for QoL), which is a methodological asset. The sample size of 277 is modest but not trivial for this niche population. The study was conducted at a single tertiary transplant center between 2018 and 2023, covering kidney, liver, and pancreas recipients within five years of transplant.

The 30% response rate is the methodological Achilles heel. Non-responders may systematically differ from responders — women experiencing more distress or less sexual activity may have been less likely to complete the survey, which would deflate the dysfunction estimates. There's no non-transplant control group, so claims that rates are "higher than the general population" rely on external comparison figures, not matched controls from the same study.

Red Flags

• 30% response rate introduces substantial non-response bias; estimates of dysfunction prevalence should be treated as lower bounds
• Single center (Mayo Clinic Arizona) limits generalizability; this is a highly specialized, likely higher-SES patient population
• No control group within the study — comparisons to general population rates use external benchmarks from different studies with different methodologies
• Funding and COI not disclosed — not inherently suspicious for a survey study, but worth noting
• Cross-sectional design cannot distinguish whether sexual dysfunction is pre-existing, transplant-related, menopausal, or driven by immunosuppressants — all plausible mechanisms that this study cannot untangle
• Transplant types (kidney, liver, pancreas) were pooled; organ-specific differences in sexual function are not reported

Strengths

• Uses four validated, standardized instruments rather than ad hoc questions
• Stratifies by menopausal status, which is appropriate and underexplored in this population
• Addresses a documented gap — prior literature on sexual health in female SOT recipients is genuinely sparse
• The 74% care-gap figure is a clean, quotable finding that doesn't require causal inference to be meaningful
• Exploratory stratification by current sexual activity status adds nuance

Verdict

A well-intentioned cross-sectional survey that does what it sets out to do: document that sexual dysfunction is common in female transplant recipients and that providers aren't asking about it. The 74% care-gap stat is the paper's strongest contribution — it doesn't require a control group or causal interpretation. The rest of the findings are suggestive but methodologically constrained by the 30% response rate and single-center design. This paper is useful as a foundation for larger, controlled studies; taken alone, it establishes prevalence signals, not conclusions. Worth a read for clinicians in transplant medicine; don't cite the dysfunction rate estimates as definitive.